Skip to main content

Table 3 Combination therapies and selected ATC level 5 medicine use per dataset

From: Determining antenatal medicine exposures in South African women: a comparison of three methods of ascertainment

 

EDR

EDR %

Clinician record

Clinician record %

Self-report

Self-report %

Master List

Master List %

Any vitamins and supplementsa

173

17.9%

815

84.3%

759

78.5%

937

96.9%

Any ARTb

397

84.1%

283

56.0%

434

91.9%

472

100%

1st linec

374

79.2%

265

56.1%

404

85.6%

448

94.9%

2nd linec

25

5.3%

18

3..8%

30

6.3%

34

7.2%

STI syndromic treatmentd

45

4.7%

38

3.9%

73

7.6%

130

13.4%

Metronidazole (P01AB01)

36

3.7%

32

3.3%

71

7.3%

116

12.0%

Ceftriaxone (J01DD04)

0

0.0%

33

3.4%

4

0.4%

36

3.7%

Benzathine penicillin (J01CE08)e

0

0.0%

11

1.1%

25

2.6%

35

3.6%

Treatment for TBf

4

0.4%

0

0.0%

4

0.4%

7

0.7%

Isoniazid (J04AC01) as TBPT

166

17.2%

3

0.3%

7

0.7%

167

17.3%

Influenza vaccine (J07BB01)

0

0.0%

225

23.3%

3

0.3%

226

23.4%

Treatment for diabetes mellitus (A10)

13

1.3%

2

0.2%

4

0.4%

13

1.3%

Glucose lowering drugs excl. insuling

13

1.3%

2

0.2%

4

0.4%

13

1.3%

Insulins (A10A)

8

0.8%

0

0.0%

0

0.0%

8

0.8%

Anti-epileptic treatments (N03)

Phenytoin (N03AB02)

1

0.10%

1

0.10%

0

0.0%

1

0.1%

Sodium valproate (N03AG01)

0

0.0%

0

0.0%

1

0.1%

1

0.1%

Psycholeptics (N05) and anti-depressants (N06)

Haloperidol (N05AA01)

1

0.1%

0

0.0%

0

0.0%

1

0.1%

Chlorpromazine (N05AD01)

2

0.2%

0

0.0%

0

0.0%

2

0.2%

Lithium (N05AN01)

1

0.1%

0

0.0%

0

0.0%

1

0.1%

Risperidone (N05AX08)

3

0.3%

0

0.1%

2

0.2%

4

0.4%

Fluoxetine (N06AA09)

3

0.3%

0

0.0%

1

0.1%

4

0.4%

Amitriptyline (N06AB03)

1

0.1%

1

0.1%

1

0.1%

3

0.3%

Mianserin (N06AX03)

1

0.1%

0

0.0%

0

0.0%

1

0.1%

  1. ACT Anatomical chemical therapeutic, ART Antiretroviral therapy, STI Sexually transmitted infection, TB, Tuberculosis disease, TBTP TB preventive therapy, EDR Electronic dispensing record
  2. a Excludes vitamin B6 which is prescribed exclusively with INH as TBPT
  3. b in 472 WLHIV
  4. c Of the 472 women on ART; 1st line NRTI backbone with NNRTI; 2nd line NRTI backbone with PI;
  5. 10 women are represented in the total having both 1st and 2nd line regimens: 3 changed to 2nd line treatment during pregnancy (2 in PHDC, 1 in self-report); 7 were due to discrepancies between the datasets
  6. dmetronidazole/ceftraixone ± azithromycin ± amoxicillin
  7. e treatment of syphilis
  8. f combination therapy of rifampcin + pyrazinamide + ethambutol + isoniazid
  9. g A10BA02 (metformin) or A10BB12 (glimepiride)